rv3391
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jun 1, 2008 (NCT00709579)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Mycobacterium tuberculosisINHIBITOR
Mycobacterium tuberculosis inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rv3391
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00709579 | Phase 3 | Jun 1, 2008 | Paul Sabatier University, Pierre Fabre, University of Geneva, University of Lausanne |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Paul Sabatier University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Pierre Fabre | For profit | 1 | 1 | 1 | 2008 |
| University of Geneva | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of Lausanne | Academic/Hospital | 1 | 0 | 1 | 2008 |
4 organizations
Page 1 / 1